Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EDIT – Editas Medicine, Inc.

Editas Medicine, Inc.
EDIT
$2.80
Name : Editas Medicine, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $251,776,560.00
EPSttm : -2.84
finviz dynamic chart for EDIT
Editas Medicine, Inc.
$2.80
2.56%
$0.07

Float Short %

8.81

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.37

EPS Last/This Y

0.85

EPS This/Next Y

0.96

Price

2.8

Target Price

3.89

Analyst Recom

2.47

Performance Q

72.84

Relative Volume

0.57

Beta

2.15

Ticker: EDIT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25EDIT3.140.050.2953127
2025-07-28EDIT2.960.050.0553037
2025-07-29EDIT2.590.050.4652385
2025-07-30EDIT2.520.060.0952645
2025-07-31EDIT2.50.060.0452968
2025-08-01EDIT2.440.060.5153280
2025-08-04EDIT2.560.060.0353305
2025-08-05EDIT2.60.060.2253606
2025-08-06EDIT2.530.060.0353486
2025-08-07EDIT2.480.060.1653396
2025-08-08EDIT2.20.060.0653495
2025-08-11EDIT2.190.060.2654201
2025-08-12EDIT2.290.060.8554286
2025-08-13EDIT3.090.070.0754524
2025-08-14EDIT2.960.060.2759770
2025-08-15EDIT3.040.060.0459475
2025-08-18EDIT2.730.050.3147288
2025-08-19EDIT2.640.060.7547834
2025-08-20EDIT2.660.060.0648083
2025-08-21EDIT2.740.060.3347936
2025-08-22EDIT2.80.060.0048044
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25EDIT3.1554.6- -1.88
2025-07-28EDIT2.9554.6- -1.88
2025-07-29EDIT2.5954.6- -1.88
2025-07-30EDIT2.5254.6- -1.88
2025-07-31EDIT2.5154.6- -1.88
2025-08-01EDIT2.4454.6- -1.88
2025-08-04EDIT2.5654.6- -1.88
2025-08-05EDIT2.6054.6- -1.88
2025-08-06EDIT2.5354.6- -1.88
2025-08-07EDIT2.4954.6- -1.88
2025-08-08EDIT2.2154.6- -1.83
2025-08-11EDIT2.1953.7- -1.83
2025-08-12EDIT2.2953.7- -1.83
2025-08-13EDIT3.0853.7- -1.83
2025-08-14EDIT2.9553.7- -1.83
2025-08-15EDIT3.0453.7- -1.84
2025-08-18EDIT2.7360.2- -2.01
2025-08-19EDIT2.6353.7- -2.01
2025-08-20EDIT2.6753.7- -2.01
2025-08-21EDIT2.7453.7- -2.01
2025-08-22EDIT2.8049.7- -2.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25EDIT-4.99-13.8810.27
2025-07-28EDIT-4.99-13.9510.27
2025-07-29EDIT-4.99-13.9510.27
2025-07-30EDIT-4.99-13.9510.27
2025-07-31EDIT-4.99-13.9510.27
2025-08-01EDIT-4.99-13.9510.27
2025-08-04EDIT-5.59-12.2810.27
2025-08-05EDIT-5.59-12.2810.27
2025-08-06EDIT-5.59-12.2810.27
2025-08-07EDIT-5.59-12.2810.27
2025-08-08EDIT-5.67-12.2810.27
2025-08-11EDIT-5.67-11.9710.27
2025-08-12EDIT-5.73-11.979.47
2025-08-13EDIT-5.73-11.979.47
2025-08-14EDIT-5.73-11.979.47
2025-08-15EDIT-5.36-11.978.81
2025-08-18EDIT-5.36-13.878.81
2025-08-19EDIT-5.36-13.878.81
2025-08-20EDIT-5.36-13.878.81
2025-08-21EDIT-5.36-13.878.81
2025-08-22EDIT-5.36-13.878.81
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.63

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.26

Insider Transactions

-5.36

Institutional Transactions

-13.87

Beta

2.15

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

7

Fair Value

Quality Score

4

Growth Score

27

Sentiment Score

17

Actual DrawDown %

97.2

Max Drawdown 5-Year %

-98.9

Target Price

3.89

P/E

Forward P/E

PEG

P/S

6.47

P/B

12.75

P/Free Cash Flow

EPS

-2.85

Average EPS Est. Cur. Y​

-2.03

EPS Next Y. (Est.)

-1.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-608.88

Relative Volume

0.57

Return on Equity vs Sector %

-1259

Return on Equity vs Industry %

-1246.1

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.19

EBIT Estimation

Editas Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 246
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today
news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance
stock history EDIT – Editas Medicine, Inc. invest stock market
stock prices EDIT premarket after hours
ticker EDIT fair value insiders trading